The latest news on the United States. Moderna has confirmed on Wednesday that its federal contract for advancing a bird flu vaccine has been terminated following a government review that cited concerns over scientific and safety benchmarks.
The mRNA-based shot was one of several candidates Moderna hoped would offset declining COVID-related revenues. While the company still sees promise in its mid-stage data and plans to pursue alternate paths, the loss of public funding could slow progress.